Diana Martinez MD
Associate Professor, Psychiatry, Columbia University College of Phys & Surg
Join to View Full Profile
1051 Riverside Drive #31New York, NY 10032
Phone+1 212-543-6628
Dr. Martinez is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1994 - 1998
Weill Cornell MedicineClass of 1994
Certifications & Licensure
NY State Medical License 1996 - 2027
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus Start of enrollment: 2019 Sep 01
- Cannabinoids for Taxane Induced Peripheral Neuropathy Start of enrollment: 2019 Sep 01
- Investigating the Effect of Dronabinol on Post-surgical Pain Start of enrollment: 2025 Sep 01
Publications & Presentations
PubMed
- Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder.Andrea J Capusan, Le Zhang, Henrik Larsson, Isabell Brikell, Diana Martinez
BMJ Mental Health. 2026-03-23 - Decisional incentive sensitivity is linked to contingency management outcome and striatal dopamine signaling in individuals with cocaine use disorder: a preliminary st...Nehal P Vadhan, Kenneth M Carpenter, Elysia Benedict, Catherine E Myers, Mark A Gluck
Addiction and Substance Abuse. 2026-01-01 - Transcranial magnetic stimulation in cocaine use disorder and the risk of seizure: a review of the evidence.Caesar G Imperio, Eric Parmon, Vaughn R Steele, Derek Blevins, Rebecca Chalme
Frontiers in Psychiatry. 2026-01-01
Press Mentions
Has the 5th Wave Arrived? COVID Cases Surging Again in MassMay 13th, 2022- With Many Cannabis Products but Limited Research, ‘Education Warranted’ for Entire Oncology WorkforceApril 28th, 2022
- Cannabis Use: Messages Remain Mixed Across DiagnosesOctober 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
